Berlin, Germany

Physician.
Researcher.
Systems thinker.

I think about how things work: the visible parts and the ones nobody talks about. Medicine taught me that the body keeps score. Systems thinking taught me that everything does.

Martha Wuya Koroma

I think in systems.

I write in clarity.

I build for impact.

Martha Wuya Koroma
Martha Wuya Koroma at a conference

Who is Martha

Perceptive, principled, and probably already three steps ahead. I see patterns where others see noise.

I trained in medicine because I wanted to understand suffering. What I found was that suffering is rarely just biological. It lives in systems, in language, in how we organise ourselves around each other.

So my work runs along a single thread, even when the titles don’t match. Clinical research taught me how systems are meant to work. Patents and a doctoral research programme taught me how to build for the people those systems fail to see. The writing names what the data leaves out. It all does the same job from different angles: surfacing what systems don’t see.

MD candidate
November 2026
Good Clinical Practice
ICH-GCP · E6(R3)
Peer-reviewed
The Lancet Psychiatry, 2025
Trial experience
Phase 3 operations
Named inventor
Three filed patents (DPMA)
Founder
MetaVoxa & GlaceGrip
01Clinical Research

How systems are meant to work

The end-to-end machinery of a trial: qualification, monitoring, deviation, safety. This is the ground I came up on, and the work I am moving toward next.

Qualification
Initiation
Monitoring
Safety
Close-out

Phase 3 Clinical Trial Observer

7 months

Inductive Quotient

  • Observed qualification, initiation, and monitoring visits end to end: site visit structure, investigator qualification verification, and ISF/TMF filing requirements.
  • Followed protocol deviation identification, communication to site staff, and CAPA documentation in real time across an active trial.
  • Direct exposure to adverse event and SAE review, concomitant medication verification, and data integrity practices under ICH-GCP.

International Research Collaborator

2024 to 2025

Global Suicide Prevention Network / The Lancet Psychiatry

  • Led primary data collection and quality assessment across assigned countries in a 105-country study; applied source data verification and quality-control methodology across diverse site environments.
  • Named collaborator on the peer-reviewed publication (The Lancet Psychiatry, 2025).
  • Assessed data completeness and accuracy; contributed findings to Bayesian statistical modelling across 105 countries.

Self-Directed Clinical Research

May 2025 to Present

Berlin, Germany

  • Produced a monitoring-plan redesign for a Phase III oncology trial, with IPCW-adjusted survival analysis and an irAE rechallenge protocol, anchored in ICH E6(R2), E9, E9(R1), and FDA adaptive design guidance.
  • Completed hands-on EDC training (Medidata Rave, REDCap) and CTMS (Veeva) through the Johns Hopkins Clinical Trial Operations specialisation.
  • Maintained study documentation aligned with TMF standards; applied ICH-GCP principles to protocol analysis and regulatory review.
Systems & standardsMedidata RaveREDCapVeeva CTMSICH-GCPICH E6(R3)TMF / ISF
03Publications, Patents & Research

Building for what the data leaves out

A peer-reviewed credit, filed patents, and preprints, most of it pointed at one question: how do you measure an experience a system was never designed to register?

Peer-reviewed publication

Evaluating the global landscape of suicide helpline services: a global survey across 105 countries

Vaghela G, et al., & Global Suicide Prevention Network Collaborators (incl. Koroma M.W.). The Lancet Psychiatry, 12, 100–110 (2025).

View on DOI

Patent · Named inventor

Candidate Culture-Calibrated Digital Biomarker System

Gebrauchsmuster, DPMA · May 2026

Patent · Named inventor

GlaceGrip

Gebrauchsmuster, DPMA · May 2026

Patent · Named inventor

Bed Device with Integrated Weighing Function for Immobile Patients

Gebrauchsmuster, DPMA · May 2026

Preprint

Designing from the Inside: Design Rationale for a Culture-Calibrated Digital Biomarker System for Adult ADHD Diagnosis

Koroma, M.W. · Zenodo, May 2026

04Practice, Education & Background

The ward before the whitepaper

Clinical training taught me that policy has a pulse; you feel it in the corridor before you read it in the literature. The rest of the record runs across medicine, strategy, security, and diplomacy. Different rooms, one way of thinking.

Clinical practice

Healthcare Professional

Sept 2024 to Present

Vivantes · Berlin

  • Clinical patient records and safety protocols under German regulatory standards, in a high-volume inpatient environment.
  • Ground-level understanding of patient eligibility, protocol-level care, and institutional compliance: the same machinery a monitor verifies, seen from inside the ward.

Earlier & cross-domain

Founder

2023 to Present

MetaVoxa, Berlin

Holding company, research company, and product venture; filed three Gebrauchsmuster with DPMA; building GDPR-compliant health-data architecture for a Phase II candidate digital biomarker validation trial.

Founder

2023 to Present

Glacé Grip (under MetaVoxa), Berlin

Auto business specialising in cooling sleeves for machinery.

Public Diplomacy & Cultural Affairs Intern

2022 to 2023

Embassy of the Republic of Sierra Leone, Berlin

Official correspondence, briefing summaries, and formal records; supported senior staff across German legal and administrative frameworks.

Diplomatic Aide & Strategic Assistant

2018 to 2020

Office of the Ambassador, Republic of Sierra Leone

Briefing files and confidential records across presidential meetings, state functions, and diplomatic receptions.

Education

MD, Surgery Track

2020 to Nov 2026

Horbachevsky Ternopil National Medical University, Ukraine

Continued via clinical placements in Germany.

MSc Cybersecurity

One-year fast-track programme

BSc Business Administration

LICCSAL Business College · GPA 4.0

Data analysis, project management, organisational strategy.

AP Research Programme

2019 to 2020

Senegal American Bilingual School, Dakar

Published original quantitative research; completed ethics certification independently.

Leadership & strategy

McKinsey Forward Programme

A selective leadership and structured-problem-solving programme, covering adaptability, communication, and the operating habits of management consulting.

Certifications & training

  • Clinical Trial Operations · Johns Hopkins
  • Drug Development & Pharmacoepidemiology · Johns Hopkins
  • Data Management for Clinical Research · Vanderbilt
  • Regulatory Compliance · University of Pennsylvania
  • Drug Development & Product Management · UC San Diego
  • Google Data Analytics
  • AWS Training & Certification
  • ICH E6(R3) Principles for Good Clinical Practice
05Writing & Thought Leadership

Naming what the data leaves out

MetaVoxa Press is where the systems argument gets made in plain language: essays on healthcare, recognition, and the experiences clinical literature tends to miss.

Martha sharing tea with an elder in Morocco
The work begins with people, not data. It always has.

Functional Pain

On the gap between what a body reports and what a system is willing to record.

Unrecognised, not invisible

The difference between being unseen and being unaccounted for, and why it matters clinically.

When the mask is also your culture

What masking costs when fitting in was never optional, and why that cost stays invisible to the clinic.

The human story always precedes the data.

The why behind everything I build.

The MetaVoxa Atrium: a vaulted hall of arches opening onto further rooms

Beyond the CV

The professional record lives here.
The rest of me lives at MetaVoxa.

MetaVoxa Atrium is the house: reading & writing, editorial cartography, interdependent community and the work that doesn’t fit on a CV. Everything that made the record possible, kept in its own rooms.

Enter the Atrium